Paul Chaplin, Bavarian Nordic CEO
Bavarian Nordic's monkeypox vaccine wins positive opinion from EMA committee
With demand rising for Bavarian Nordic’s smallpox vaccine, European officials have given the thumbs up to expand the label to include monkeypox.
Imvanex, marketed as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.